Lisata Therapeutics, Inc.LSTANASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-27.2%
5Y CAGR-0.9%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-27.2%/yr
vs +154.2%/yr prior
5Y CAGR
-0.9%/yr
Recent deceleration
Acceleration
-181.4pp
Decelerating
Percentile
P74
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 32.65% |
| Q3 2025 | 9.26% |
| Q2 2025 | 1.82% |
| Q1 2025 | 0.00% |
| Q4 2024 | 6.78% |
| Q3 2024 | 3.28% |
| Q2 2024 | 6.15% |
| Q1 2024 | 1.52% |
| Q4 2023 | -1.54% |
| Q3 2023 | -30.00% |
| Q2 2023 | 35.06% |
| Q1 2023 | 36.36% |
| Q4 2022 | 84.64% |
| Q3 2022 | -392.50% |
| Q2 2022 | -52.38% |
| Q1 2022 | 38.24% |
| Q4 2021 | 2.30% |
| Q3 2021 | -21.68% |
| Q2 2021 | 50.17% |
| Q1 2021 | -1.41% |
| Q4 2020 | 34.19% |
| Q3 2020 | -157.33% |
| Q2 2020 | 233.21% |
| Q1 2020 | 20.70% |
| Q4 2019 | -0.71% |
| Q3 2019 | 4.08% |
| Q2 2019 | -11.36% |
| Q1 2019 | -19.78% |
| Q4 2018 | -0.92% |
| Q3 2018 | 14.29% |
| Q2 2018 | 18.54% |
| Q1 2018 | -63.26% |
| Q4 2017 | 15.37% |
| Q3 2017 | -108.69% |
| Q2 2017 | 488.89% |
| Q1 2017 | -22.64% |
| Q4 2016 | 16.41% |
| Q3 2016 | 17.94% |
| Q2 2016 | 36.46% |
| Q1 2016 | 69.49% |